ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
4.840
-0.440 (-8.33%)
At close: Aug 1, 2025, 4:00 PM
4.610
-0.230 (-4.75%)
After-hours: Aug 1, 2025, 7:51 PM EDT
Company Description
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound.
The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.
ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
ENDRA Life Sciences Inc.
| Country | United States |
| Founded | 2007 |
| IPO Date | May 9, 2017 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 21 |
| CEO | Alexander Tokman |
Contact Details
Address: 3600 Green Court, Suite 350 Ann Arbor, Michigan 48105-1570 United States | |
| Phone | 734 335 0468 |
| Website | endrainc.com |
Stock Details
| Ticker Symbol | NDRA |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001681682 |
| CUSIP Number | 29273B104 |
| ISIN Number | US29273B3024 |
| Employer ID | 26-0579295 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Alexander Y. Tokman | Acting Chief Executive Officer and Chairman |
| Richard Jacroux | Chief Financial Officer and Secretary |
| Michael Thornton Ph.D. | Chief Technology Officer |
| Dr. Jonathan Behr Ph.D. | Co-Founder |
| Ziad Rouag | Head of Regulatory and Clinical Affairs |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 25, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jul 23, 2025 | 8-K | Current Report |
| Jul 16, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jul 9, 2025 | 8-K | Current Report |
| Jul 9, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Jun 11, 2025 | 8-K | Current Report |
| May 30, 2025 | 8-K | Current Report |
| May 15, 2025 | 10-Q | Quarterly Report |
| May 15, 2025 | 8-K | Current Report |
| May 9, 2025 | DRS | [Cover] Draft Registration Statement |